Abstract:Bladder cancer is currently considered the most common malignancy of the urinary tract. Thulium laser en bloc resection of bladder tumor (TmLRBT) and plasmakinetic transurethral resection of bladder tumor (PK-TURBT) are two alternative common procedures used in our department to manage patients with primary non-muscle invasive bladder cancer (NMIBC) over the past decade. In this work, the safety and efficacy of TmLRBT were retrospectively compared to those of PK-TURBT in patients with primary NMIBC. From January 2013 to December 2015, 256 patients diagnosed with primary NMIBC were selected for this retrospective study. A total of 136 consecutive patients diagnosed with primary NMIBC were enrolled in the TmLRBT group. A similar historical cohort of 120 consecutive patients who underwent PK-TURBT was used to compare the two procedures. Clinical data, including age, gender, tumor characteristics, operation duration, hospitalization, irrigation, catheterization, and intraoperative and postoperative complications, were recorded. There were no significant differences in age, gender, mean tumor size, mean tumor number, tumor location, or risk between the TmLRBT and PK-TURBT groups. The TmLRBT group was associated with a significantly shorter operation duration (25.96 ± 21.19 min vs 37.18 ± 25.77 min, P = 0.018) and a shorter hospitalization time (3.11 ± 1.05 days vs 5.24 ± 2.06 days, P = 0.036). The postoperative irrigation time (6.33 ± 4.05 h vs 14.76 ± 6.28 h, P = 0.027) and catheterization time (2.03 ± 1.61 days vs 4.27 ± 1.17 days, P = 0.035) in the TmLRBT group were lower than those in the PK-TURBT group. No significant differences in fever and rebleeding were found in the TmLRBT and PK-TURBT groups. There were no significant differences in the overall, low-risk, intermediate-risk, and high-risk recurrence-free rates between the two groups ( P = 0.43, P = 0.68, P = 0.71, and P = 0.24, respectively). The proportion of bladder detrusor muscle (BDM) identified in pathologic specimens of the TmLRBT group was higher than that in the PK-TURBT group ( P = 0.006). TmLRBT may reduce operation duration time, hospitalization time, postoperative irrigation time, and catheterization time. TmLRBT is considered safer and more effective in treating primary NMIBC. Recurrence-free rates did not differ between groups.

Plasmakinetic bipolar transurethral resection versus traditional transurethral resection of bladder cancer:a systematic review

Application of Suprapubic Needle Aspiration of Bladder to Transurethral Bipolar Plasmakinetic Resection of the Prostate

Comparison of Monopolar and Bipolar Transurethral Resection of Non-Muscle Invasive Bladder Cancer

A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer

Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis.

Effect observation on different transurethral resection patterns for treating patients with non-muscle invasive bladder cancer

Outcomes and Prognostic Factors of Transurethral Bipolar Plasmakinetic Resection of the Bladder Tumor in Renal Transplant Recipients

Transurethral plasma kinetic resection of superficial bladder tumor

Comparison of Monopolar Versus Bipolar Repeat Transurethral Resection of Bladder Tumours

Analysis of efficacy of transurethral resection in saline button electrode plasma vaporization in non-muscle-invasive bladder cancer

Transurethral bipolar plasmakinetic prostatectomy for benign prostatic hyperplasia in high-risk and senior patients in China: a systematic review and meta-analysis

Transurethral Prostatectomy with the Bipolar Plasmakinetic Technique for Benign Prostate Hyperplasia

Novel transurethral laser surgery versus conventional TURBT for treating non-mus-cle invasive bladder cancer:a systematic review and met a-analysis

A Comparative Study of Transurethral Plasmakinetic Resection Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia

Efficiency of transurethral en‐bloc resection vs. conventional transurethral resection for non‐muscle‐invasive bladder cancer: An umbrella review

Comparison of efficacy and safety between transurethral plasma kinetic resection of prostate and conventional transurethral resection of prostate for treatment of benign prostate hyperplasia

Transurethral Resection of Prostate with Bipolar Plasmakinetic for the Treatment of High Risk Benign Prostatic Hyperplasia Patients

Monopolar versus bipolar transurethral resection of bladder Tumour: post-hoc analysis of a prospective trial

Transurethral bipolar plasmakinetic resection combined with 2 μm laser vaporization in the treatment of larger-volumed benign prostate hyperplasia

Efficacy and safety of a novel 450 nm blue diode laser versus plasmakinetic electrocautery for the transurethral resection of non-muscle invasive bladder cancer: The protocol and result of a multicenter randomized controlled trial

Holmium Laser vs.Bipolar Transurethral Resection in Saline for Resection of Non-muscle Invasive Bladder Cancer: Prospective,Randomized Controlled Trial